180 related articles for article (PubMed ID: 22039867)
1. Platinum formulations as anticancer drugs clinical and pre-clinical studies.
P Farrell N
Curr Top Med Chem; 2011; 11(21):2623-31. PubMed ID: 22039867
[TBL] [Abstract][Full Text] [Related]
2. Anticancer platinum (IV) prodrugs with novel modes of activity.
Chin CF; Wong DY; Jothibasu R; Ang WH
Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of platinum-based anticancer complexes.
Butler JS; Sadler PJ
Curr Opin Chem Biol; 2013 Apr; 17(2):175-88. PubMed ID: 23395452
[TBL] [Abstract][Full Text] [Related]
4. XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents.
Hall MD; Foran GJ; Zhang M; Beale PJ; Hambley TW
J Am Chem Soc; 2003 Jun; 125(25):7524-5. PubMed ID: 12812486
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers for delivery of platinum anticancer drugs.
Oberoi HS; Nukolova NV; Kabanov AV; Bronich TK
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1667-85. PubMed ID: 24113520
[TBL] [Abstract][Full Text] [Related]
6. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
[TBL] [Abstract][Full Text] [Related]
7. Advances in platinum chemotherapeutics.
Harper BW; Krause-Heuer AM; Grant MP; Manohar M; Garbutcheon-Singh KB; Aldrich-Wright JR
Chemistry; 2010 Jun; 16(24):7064-77. PubMed ID: 20533453
[TBL] [Abstract][Full Text] [Related]
8. The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
Montaña AM; Batalla C
Curr Med Chem; 2009; 16(18):2235-60. PubMed ID: 19519389
[TBL] [Abstract][Full Text] [Related]
9. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J
Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
[TBL] [Abstract][Full Text] [Related]
10. Polymeric biomaterials for the delivery of platinum-based anticancer drugs.
Kim J; Pramanick S; Lee D; Park H; Kim WJ
Biomater Sci; 2015 Jul; 3(7):1002-17. PubMed ID: 26221935
[TBL] [Abstract][Full Text] [Related]
11. Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery.
Yang J; Liu W; Sui M; Tang J; Shen Y
Biomaterials; 2011 Dec; 32(34):9136-43. PubMed ID: 21889206
[TBL] [Abstract][Full Text] [Related]
12. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
[TBL] [Abstract][Full Text] [Related]
13. Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.
Parker JP; Ude Z; Marmion CJ
Metallomics; 2016 Jan; 8(1):43-60. PubMed ID: 26567482
[TBL] [Abstract][Full Text] [Related]
14. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
Shi H; Cheng Q; Yuan S; Ding X; Liu Y
Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
[TBL] [Abstract][Full Text] [Related]
15. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.
Paraskar A; Soni S; Roy B; Papa AL; Sengupta S
Nanotechnology; 2012 Feb; 23(7):075103. PubMed ID: 22275055
[TBL] [Abstract][Full Text] [Related]
16. Functionalization of Platinum Complexes for Biomedical Applications.
Wang X; Wang X; Guo Z
Acc Chem Res; 2015 Sep; 48(9):2622-31. PubMed ID: 26247558
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
18. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
Najjar A; Rajabi N; Karaman R
Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
[TBL] [Abstract][Full Text] [Related]
19. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance.
Xie P; Wang Y; Wei D; Zhang L; Zhang B; Xiao H; Song H; Mao X
J Mater Chem B; 2021 Jul; 9(26):5173-5194. PubMed ID: 34116565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]